Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: FlatTaxMan who wrote (405)	11/8/1998 7:25:00 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 642

Sorry, but that was mostly a crock of you-know-what. Prozac is not there to treat anything, but what it does treat, it treats well. Pateints shouldn't be making decisions about what med to take, and if a dr. simply says okay when a patient asks without thinking, the doc is far from being a legit. doc. BTW, the so-called strange situation leading to the removal of l-tryptophan was a problem called eosinophilic myalgic syndrome, well beyond a minor little nothing. However, it wasn't likely the l-tryptophan itself responsible. Nevertheless, who decided that taking an amino acid precursor by mouth could somehow change the serotonin levels in the brain, let alone in a way necessary to alleviate depression, even if serotonin is a later product of tryptophan metabolism (5-hydroxy-tryptamine)? Just my 2 cents. Have a nice monday, Marshall